Is my dosing and reconstitution with bacteriostatic water appropriate for the peptide stack comprising Retatrutide, MOTSc, the Glow blend (BPC157, TB500, GHKCu), CJC1295, and Ipamorelin? Sources: U.S. Food and Drug Administration (FDA) Compounding and the FDA (503A & 503B guidance) FDA warning letters on unapproved peptide products National Institutes of Health (NIH) PubMed The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions Peptide Therapy Prescription in 2025: Your Safe Guide